Showing results (81-90 of 141) with videos related to
Sort By:
Pageof 15
Diabetologia|November 20, 2004
Short-term infusion of interleukin-6 does not induce insulin resistance in vivo or impair insulin signalling in ratsV Rotter Sopasakis, B-M Larsson, A Johansson, et al.Cell Death and Differentiation|January 10, 2004
p53 is a regulator of macrophage differentiationD Matas, M Milyavsky, I Shats, et al.Nature|December 13, 1984
Cooperation between gene encoding p53 tumour antigen and ras in cellular transformationL F Parada, H Land, R A Weinberg, et al.Oncogene|December 1, 1993
Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineageR Aloni-Grinstein, I Zan-Bar, I Alboum, et al.Cancer Letters|February 5, 2000
An intragenic deletion of nuclear localization signal-1 of p53 tumor suppressor gene results in loss of apoptosis in murine fibroblastsW Zhao, C He, V Rotter, et al.Cancer Investigation|July 4, 2002
Altered subcellular localization of p53 in estrogen-dependent and estrogen-independent breast cancer cellsG Lilling, J Nordenberg, V Rotter, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 10, 2001
Thiazolidinediones (PPARgamma agonists) but not PPARalpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytesU Smith, S Gogg, A Johansson, et al.Brain Research. Molecular Brain Research|September 5, 2001
p53 is dispensable for apoptosis but controls neurogenesis of mouse dentate gyrus cells following gamma-irradiationD Uberti, L Piccioni, M Cadei, et al.Cancer Gene Therapy|October 23, 2010
Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapiesI Goldstein, V Marcel, M Olivier, et al.Oncogene|September 20, 2005
Repression of the MSP/MST-1 gene contributes to the antiapoptotic gain of function of mutant p53A Zalcenstein, L Weisz, P Stambolsky, et al.Pageof 15